DanielCDanilaMD

PubMed

• The Impact of Circulating Tumor Cell HOXB13 RNA Detection in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide.
  Park, J., Susan Halabi, Siyuan Guo, Joseph J Park, David M Nanus, Daniel J George, Emmanuel S Antonarakis, Daniel Costin Danila, Russell Zelig Szmulewitz, Donald P McD...> ;Clinical Cancer Research. 2024 Mar 15
• 2 citations
  Xaluritamig, a STEAP1 × CD3 XmAb 2+1 Immune Therapy for Metastatic Castration-Resistant Prostate Cancer: Results from Dose Exploration in a First-in-Human Study.
  Kelly, W., Danila, D., Lin, C., Lee, J., Matsubara, N., Ward, P., Armstrong, A., Pook, D., Kim, M., Dorff, T., Fischer, S., Lin, Y., Horvath, L., Sumey, C., Yang, Z., ...> ;Cancer Discovery. 2024 Jan 12
• Evaluating Immune-Related Adverse Events Using PRO-CTCAE in a Phase II Study of Ipilimumab for Hormone-Sensitive Prostate Cancer.
  de Almeida, D., Cohn, E., Baser, R., Anderson, J., Danila, D., Morris, M., Slovin, S., Abida, W., Scher, H., Autio, K.> ;Journal of Immunotherapy and Precision Oncology. 2023 Nov 1
• Cancer Associated Macrophage-like Cells Are Prognostic for Highly Aggressive Prostate Cancer in Both the Non-Metastatic and Metastatic Settings.
  Daniel J Gironda, Raymond C Bergan, R Katherine Alpaugh, Daniel C Danila, Tuan L Chuang, Brenda Y Hurtado, Thai Ho, Daniel L Adams> ;Cancers. 2023 Jul 22
• Health-related quality of life in GALAHAD: A multicenter, open-label, phase 2 study of niraparib for patients with metastatic castration-resistant prostate cancer and ...
  Matthew R Smith, Shahneen Sandhu, Daniel J George, Kim Nguyen Chi, Fred Saad, Antoine Thiery-Vuillemin, Olaf Stàhl, David Olmos, Daniel C Danila, Rustem Gafanov, Elena...> ;Journal of Managed Care & Specialty Pharmacy. 2023 Jul 1
• 1 citations
  Clinical Impact of a Rapid Genetic Testing Model for Advanced Prostate Cancer Patients.
  Kelsey E Breen, Heather Symecko, Kelsey Spielman, Rebecca Gebert, Ibrahim H Shah, Stacy Pundock, Melissa Batson, Vivek K Narayan, Zsofia K Stadler, Karen A Autio, Wass...> ;The Journal of Urology. 2023 May 1
• 3 citations
  PSMA-positive Circulating Tumor Cell Detection and Outcomes with Abiraterone or Enzalutamide Treatment in Men with Metastatic Castrate-resistant Prostate Cancer.
  Santosh Gupta, Susan Halabi, Qian Yang, Akash Roy, Alisa Tubbs, Yamini Gore, Daniel J George, David M Nanus, Emmanuel S Antonarakis, Daniel C Danila, Russell Z Szmulew...> ;Clinical Cancer Research. 2023 May 15
• 8 citations
  Gene-based Confirmatory Germline Testing Following Tumor-only Sequencing of Prostate Cancer.
  Hong Truong, Kelsey Breen, Subhiksha Nandakumar, Daniel D Sjoberg, Yelena Kemel, Nikita Mehta, Andrew T Lenis, Peter A Reisz, Jessica Carruthers, Nicole Benfante, Vija...> ;European Urology. 2023 Jan 1
• 2 citations
  Automated Bone Scan Index to Optimize Prostate Cancer Working Group Radiographic Progression Criteria for Men With Metastatic Castration-Resistant Prostate Cancer.
  Aseem Anand, Glenn Heller, Joseph Fox, Daniel C Danila, Anders Bjartell, Lars Edenbrandt, Steven M Larson, Howard I Scher, Michael J Morris> ;Clinical Genitourinary Cancer. 2022 Jun 1
• 3 citations
  Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data quality.
  Niamh M Keegan, Samantha E Vasselman, Ethan S Barnett, Barbara Nweji, Emily A Carbone, Alexander Blum, Michael J Morris, Dana E Rathkopf, Susan F Slovin, Daniel C Dani...> ;The Prostate. 2022 Aug 1
• 76 citations
  Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial.
  Matthew R Smith, Howard I Scher, Shahneen Sandhu, Eleni Efstathiou, Primo N Lara Jr, Evan Y Yu, Daniel J George, Kim N Chi, Fred Saad, Olof Ståhl, David Olmos, Daniel ...> ;The Lancet. Oncology. 2022 Mar 1
• 3 citations
  Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prosta...
  Karen A. Autio, Emmanuel S. Antonarakis, Tina M. Mayer, Daniel H. Shevrin, Mark N. Stein, Ulka N. Vaishampayan, Michael J. Morris, Susan F. Slovin, Elisabeth I. Heath,...> ;European Urology Open Science. 2021 Dec 1
• 25 citations
  Differences in prostate cancer genomes by self-reported race: Contributions of genetic ancestry, modifiable cancer risk factors, and clinical factors
  Konrad H. Stopsack, Subhiksha Nandakumar, Kanika Arora, Bastien Nguyen, Samantha E. Vasselman, Barbara Nweji, Sean McBride, Michael J. Morris, Dana E. Rathkopf, Susan ...> ;Clinical Cancer Research. 2021 Oct 19
• 20 citations
  Development and validation of circulating tumour cell enumeration (Epic Sciences) as a prognostic biomarker in men with metastatic castration-resistant prostate cancer
  Howard I. Scher, Andrew J. Armstrong, Joseph D. Schonhoft, Audrey Gill, Jimmy L. Zhao, Ethan Barnett, Emily Carbone, J. Lu, Emmanuel S. Antonarakis, Jun Luo, Scott T. ...> ;European Journal of Cancer. 2021 Apr 21
• 11 citations
  Circulating Tumor Cell Chromosomal Instability and Neuroendocrine Phenotype by Immunomorphology and Poor Outcomes in Men with mCRPC Treated with Abiraterone or Enzalut...
  Landon C. Brown, Susan Halabi, Joseph D. Schonhoft, Qian Yang, Jun Luo, David M. Nanus, Paraskevi Giannakakou, Russell Z. Szmulewitz, Daniel C. Danila, Ethan Barnett, ...> ;Clinical Cancer Research. 2021 Jul 15
• 9 citations
  Attenuation of SRC Kinase Activity Augments PARP Inhibitor–mediated Synthetic Lethality in BRCA2-altered Prostate Tumors
  Goutam Chakraborty, Nabeela Khan Patail, Rahim Hirani, Subhiksha Nandakumar, Ying Z. Mazzu, Yuki Yoshikawa, Mohammad Omar Atiq, Lina E. Jehane, Konrad H. Stopsack, Gwo...> ;Clinical Cancer Research. 2021 Mar 15
• 35 citations
  Prospective Multicenter Study of Circulating Tumor Cell AR-V7 and Taxane Versus Hormonal Treatment Outcomes in Metastatic Castration-Resistant Prostate Cancer
  Andrew J. Armstrong, Jun Luo, David M. Nanus, Paraskevi Giannakakou, Russell Z. Szmulewitz, Daniel C. Danila, Patrick Healy, Monika Anand, William R. Berry, Tian Zhang...> ;JCO Precision Oncology. 2020 Oct 28
• 32 citations
  Practical Considerations and Challenges for Germline Genetic Testing in Patients With Prostate Cancer: Recommendations From the Germline Genetics Working Group of the ...
  Dhawan, M. S., , , , , , , , , , , , , , , , , , , , , , , , , , > ;JCO Oncology Practice. 2020 Sep 28
• 2 citations
  Antibody-Drug Conjugates in Prostate Cancer.
  Daniel C. Danila> ;Clinical Advances in Hematology & Oncology. 2020 Aug 1
• 27 citations
  Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study
  Karen A. Autio, Christopher A. Klebanoff, David Schaer, John S. Kauh, Susan F. Slovin, Matthew Adamow, Victoria S. Blinder, Manisha Brahmachary, Michelle Carlsen, Eliz...> ;Clinical Cancer Research. 2020 Aug 26
• Reply by Authors.
  Kristina Stuopelyte, Rasa Sabaliauskaite, Arnas Bakavicius, Benedikta S Haflidadóttir, Tapio Visakorpi, Riina-Minna Väänänen, Chintan Patel, Daniel C Danila, Hans Lilj...> ;The Journal of Urology. 2020 Jul 1
• 89 citations
  Platinum-Based Chemotherapy in Metastatic Prostate Cancer With DNA Repair Gene Alterations
  Jose Mauricio Mota, Ethan Barnett, Jones T. Nauseef, Bastien Nguyen, Konrad H. Stopsack, Andreas Wibmer, Jessica Flynn, Glenn Heller, Daniel C. Danila, Dana E. Rathkop...> ;JCO Precision Oncology. 2020 Apr 16
• 5 citations
  First-in-Humans Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted PET
  Simone Krebs, Darren R. Veach, Lukas M. Carter, Milan Grkovski, Monica Fornier, Michael Mauro, Martin H. Voss, Daniel C. Danila, Eva Burnazi, Manda Null, Kevin Staton,...> ;Journal of Nuclear Medicine. 2020 Mar 13
• 20 citations
  A Phase I Trial of IGF-1R Inhibitor Cixutumumab and mTOR Inhibitor Temsirolimus in Metastatic Castration-resistant Prostate Cancer.
  Deaglan Joseph McHugh, Jay Chudow, Mia DeNunzio, Susan F. Slovin, Daniel C. Danila, Michael J. Morris, Howard I. Scher, Dana E. Rathkopf> ;Clinical Genitourinary Cancer. 2020 Jan 11
• 39 citations
  Phase I Study of DSTP3086S, an Antibody-Drug Conjugate Targeting Six-Transmembrane Epithelial Antigen of Prostate 1, in Metastatic Castration-Resistant Prostate Cancer.
  Daniel C. Danila, Russell Z. Szmulewitz, Ulka N. Vaishampayan, Celestia S. Higano, Ari David Baron, Houston Gilbert, Flavia Brunstein, Marija Milojic-Blair, Bei Wang, ...> ;Journal of Clinical Oncology. 2019 Nov 5
• Join now to see all